NCT04096027View on ClinicalTrials.gov

Cabergoline Before or After Oocyte Collection for Follicular Resolution

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 23, 2019

Primary Completion Date

June 10, 2021

Study Completion Date

June 10, 2021

Conditions
Infertility, Female
Interventions
DRUG

Cabergoline Pill

0.5 mg cabergoline pill taken orally

Trial Locations (1)

89117

Fertility Center of Las vegas, Las Vegas

All Listed Sponsors
lead

Fertility Center of Las Vegas

INDUSTRY

NCT04096027 - Cabergoline Before or After Oocyte Collection for Follicular Resolution | Biotech Hunter | Biotech Hunter